Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial.

Matthew ReaneyPrithvi AddepalliVeleka AllenJohn A SpertusChantal DolanAmy J SehnertJennifer T Fine

Published in: PharmacoEconomics - open (2022)

Results suggest that HCMSQ is fit for purpose in capturing HCM symptoms and may provide evidence of treatment benefit from the patients' perspectives.

Keyphrases

hypertrophic cardiomyopathy
phase iii
left ventricular
clinical trial
open label
end stage renal disease
phase ii
chronic kidney disease
newly diagnosed
ejection fraction
patient reported
double blind
randomized controlled trial
study protocol
heart failure
physical activity
combination therapy
replacement therapy